LONDON, May 9, 2014 /PRNewswire/ --
The US markets finished on a mixed note on Thursday, May 08, 2014, with the NASDAQ Composite closing at 4,051.50, down 0.40%, the Dow Jones Industrial Average ending the session at 16,550.97, up 0.20% and the S&P 500 finishing 0.14% lower at 1,875.63. During the trading session, five out of ten sectors finished on a positive note. A number of stocks saw large movements, including Assured Guaranty Ltd (NYSE: AGO), Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE), Neuralstem Inc. (NYSE MKT: CUR) and Kennedy-Wilson Holdings Inc. (NYSE: KW). Free technical research on AGO, AMPE, CUR and KW can be downloaded upon signing up at:
On Thursday, shares in Assured Guaranty Ltd fluctuated between $24.26 and $25.71 before ending the session 6.42% higher at $25.52. Shares in the company reported a trading volume of 4.17 million shares, above its three months average volume of 2.16 million shares. Assured Guaranty Ltd's shares have gained 6.24% in the previous three trading sessions and 5.98% in the last one month. Additionally, the stock has advanced 8.18% on YTD basis. The stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $24.85 is above its 200-day moving average of $22.40. The company's stock traded at a PE ratio of 9.78. On May 07, 2014, Assured Guaranty Ltd also announced its Q1 FY2014 (period ended March 31, 2014) financial results. The company reported Q1 FY2014 2014 net income of $42 million, or $0.23 per share, compared with Q1 FY 2013 net loss of $144 million, or $0.74 per share. Sign up today to read free research on AGO at:
Ampio Pharmaceuticals Inc.'s stock surged 11.88% on Thursday, closing the day at $6.50. The stock recorded a trading volume of 2.68 million shares, much above its three months average volume of 0.82 million shares. The stock oscillated between $6.48 and $7.39 during the trading session. Ampio Pharmaceuticals Inc.'s stock has gained 3.17% over the previous three trading sessions and 14.04% in the last one month. However, the stock has declined 8.84% since the start of this year. The S&P 500 Health Care Sector Index mapped a loss of 0.53% during the trading session and 1.20% in the previous three trading sessions. The stock is trading above its 50-day moving average. Ampio Pharmaceuticals Inc.'s 50-day moving average of $6.27 is below its 200-day moving average of $7.29. Further, shares of the company have has a Relative Strength Index (RSI) of of 44.53. Sign up today to read free research on AMPE at:
On Thursday, Neuralstem Inc.'s stock recorded a trading volume of 1.00 million shares, close to its three months average volume of 1.11 million shares. The stock ended the day at $3.29, which was 4.44% above its previous day's closing, and registered an intraday range of $3.23 and $3.42. Neuralstem Inc.'s shares have gained 3.13% in the last three months and 13.06% on YTD basis. However, the stock has lost 23.49% in the previous one month. The S&P 500 Health Care Sector Index fell by 0.53% during the trading session, while the index has charted up 0.78% in the last one month. The company's stock is trading below its 50-day moving average. Neuralstem Inc.'s 50-day moving average of $3.90 is above its 200-day moving average of $2.85. Moreover, shares of the company have an RSI of 33.54. Sign up today to read free research on CUR at:
Shares in Kennedy-Wilson Holdings Inc. finished Thursday's session 5.10% higher at $23.10. A total of 1.01 million shares were traded, above its three months average volume of 0.44 million shares. The stock moved between $22.27 and $23.27 during the session. Over the previous three trading sessions and in last one month, Kennedy-Wilson Holdings Inc.'s stock has advanced 1.67% and 0.22%, respectively. Additionally, the stock has advanced 3.82% from the year's start. On May 07, 2014, Kennedy-Wilson Holdings Inc. reported its Q1 FY 2014 (period ended March 31, 2014) financial results. The company informed that its adjusted net income during the quarter increased to $34.3 million, or $0.39 per basic share, compared with $13.2 million, or $0.21 per basic share, in Q1 FY 2013. Moreover, the company announced that during the reported quarter its adjusted EBITDA to shareholders rose 117% to $69.2 million, compared with $31.9 million in the prior year quarter. Sign up today to read free research on KW at:
=============== EDITOR'S NOTES: ===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.